During the latter stage of liver cancer, the survival rate of patients with positive expression of HIF-1α was significantly lower than that of patients with negative HIF-1α expression, possibly due to higher risk of recurrence, metastasis, and resistance to radiotherapy and chemotherapy. Here, HIF1A is linked to liver cancer.